ResearcherFirst Affiliated Hospital of Kunming Medical UniversityNo recent work listed

Zhe Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3961-5398; OpenAlex author ID A5115603599. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2021: 1 paper

Papers 1

Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer. Last author DOI 10.7150/jca.54576 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shujie Wang · 1 shared paper, 2021 · strength 0.11
- Paper Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer. DOI 10.7150/jca.54576 ↗
Lijuan Yang · 1 shared paper, 2021 · strength 0.11
- Paper Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer. DOI 10.7150/jca.54576 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.